Soluble CD40 ligand, interleukin (IL)-6, and hemostatic parameters in metabolic syndrome patients with and without overt ischemic heart disease
Background and aim: Soluble CD40 ligand (sCD40L, also known as CD154) is a marker for platelet activation which could increase coagulation and inflammation. In this case-control study, we aimed to assess the levels of plasma sCD40L, IL-6, and some hemostatic parameters in patients with metabolic syn...
Main Authors: | Nader El-Shahhat, Mahmoud M. Ramadan, Nader El-Malkey, Ashraf A. Omar, Ibrahim A. Abd El-Aal, Asmaa Eneen |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2011-09-01
|
Series: | The Egyptian Heart Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1110260811000251 |
Similar Items
-
Relationship of serum soluble CD40 ligand and interleukin-18 levels in patients with cerebral infarction
by: Qing Zou, et al.
Published: (2016-07-01) -
Effects of IgG from the serum of ischemic stroke patients on hemostasis
by: Tetiana Katrii, et al.
Published: (2021-05-01) -
Soluble CD40 Ligand Levels in Children with Newly Diagnosed Graves’ Disease
by: Kotb Abbass Metwalley, et al.
Published: (2020-06-01) -
HEMOSTATIC DISORDERS IN LIVER DISEASES
by: A. F. Minov, et al.
Published: (2010-06-01) -
Clinicomorphological characteristics of acute gastroduodenal erosions and ulcers in unstable course of ischemic heart disease and contribution of microcirculatory,hemostatic and gastric functional disorders to their development
by: V V Chernin, et al.
Published: (2003-02-01)